This dietary supplement is recommended to protect the joints of large dog breeds
Reig Jofre, a pharma company listed on the Spanish stock market, has acquired Bioiberica’s portfolio of specialized joint health finished pharmaceutical products and nutraceuticals for the treatment of arthrosis and other arthropathies. It is also expanding its product portfolio with medicines and health products based on chondroitin sulfate, glucosamine sulfate, the combination of both and hyaluronic acid, among which are leading brands in the Spanish market and widely-known by prescribers and patients, and which enjoy a strong presence in European markets such as France, Finland and Portugal.
Nutramax Laboratories Consumer Care, Inc. today announced the publication of a meta-analysis that provides evidence for the symptomatic efficacy of glucosamine and chondroitin as combination therapy for patients with osteoarthritis (OA) of the knee. The results of the meta-analysis, which appear in the November 18 issue of Scientific Reports, conclude that the combination of glucosamine and chondroitin is associated with significant improvement in pain relief and functional enhancement, compared to placebo, while avoiding the high rate of gastrointestinal (GI) adverse effects (AEs) observed in patients receiving celecoxib, a selective non-steroidal anti-inflammatory drug (NSAID).